UNSPSC 51343827: Daclatasvir/Sofosbuvir

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM800. This VA Drug Class (AM800) classifies this compound as belonging to the group ANTIVIRALS.

UNSPSC 51343827 Daclatasvir/Sofosbuvir is a Commodity code that in practice covers pharmaceutical procurement by state and local health authorities, though recent activity under this specific code shows a mismatch between the narrow hepatitis-C antiviral scope and the actual products being solicited. The Illinois Department of Public Health and Seminole County, Florida have both used this code designation for antibiotic and emergency-response pharmaceutical buys, suggesting either misclassification in state procurement systems or administrative reuse of a standing code for general pharmaceutical warehouse contracts. State health departments and county public-health bodies are the primary issuing entities under this code tier, typically purchasing through cooperative frameworks such as MMCAP Infuse or direct competitive bidding.

Recent activity centers in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC via MMCAP Infuse on August 28, 2026, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets totaling $2,999,999.11 over 12 months plus renewal options through an Invitation for Bid process. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026, for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the county's Community Health Building; the bid response deadline was July 26, 2023. Both procurements are designed to support public-health initiatives and include delivery, insurance, E-Verify, and drug-free workplace compliance requirements. The code shows limited recent activity and appears underutilized relative to its nominal scope, suggesting either a classification gap in state and local procurement systems or infrequent standalone solicitation for the specific antiviral products the code nominally covers.